Showing results (301-310 of 379) with videos related to

Sort By:
Pageof 38
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 13, 2024
Elexacaftor/tezacaftor/ivacaftor improves chronic rhinosinusitis detected by magnetic resonance imaging in children with cystic fibrosis on long-term therapy with lumacaftor/ivacaftorLena Wucherpfennig, Johanna K Z Becker, Felix Wuennemann, et al.
Allergy|August 30, 2021
IL-37 regulates allergic inflammation by counterbalancing pro-inflammatory IL-1 and IL-33Alexandra Schröder, Lars P Lunding, Ulrich M Zissler, et al.
Annals of the American Thoracic Society|September 10, 2024
Longitudinal Magnetic Resonance Imaging of Changes in Lung Morphology and Perfusion in Children with Cystic Fibrosis From Infancy through AdolescenceMark O Wielpütz, Mirjam Stahl, Simon M F Triphan, et al.
Computers in Biology and Medicine|January 11, 2024
Characterization of transient and progressive pulmonary fibrosis by spatially correlated phase contrast microCT, classical histopathology and atomic force microscopyLorenzo D'Amico, Angelika Svetlove, Elena Longo, et al.
Annals of the American Thoracic Society|March 21, 2023
Effects of Lumacaftor/Ivacaftor on Cystic Fibrosis Disease Progression in Children 2 through 5 Years of Age Homozygous for F508del-CFTR: A Phase 2 Placebo-controlled Clinical TrialMirjam Stahl, Jobst Roehmel, Monika Eichinger, et al.
ERJ Open Research|April 3, 2023
Magnetic resonance imaging detects onset and association with lung disease severity of bronchial artery dilatation in cystic fibrosisPatricia Leutz-Schmidt, Daiva-Elzbieta Optazaite, Olaf Sommerburg, et al.
Tissue Engineering. Part A|October 16, 2014
Bronchoalveolar sublineage specification of pluripotent stem cells: effect of dexamethasone plus cAMP-elevating agents and keratinocyte growth factorKatherina Katsirntaki, Christina Mauritz, Ruth Olmer, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 24, 2018
Antisense oligonucleotide eluforsen improves CFTR function in F508del cystic fibrosisIsabelle Sermet-Gaudelus, John P Clancy, David P Nichols, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 17, 2021
Fibroblast Activation Protein-Specific PET/CT Imaging in Fibrotic Interstitial Lung Diseases and Lung Cancer: A Translational Exploratory StudyManuel Röhrich, Dominik Leitz, Frederik M Glatting, et al.
The Lancet. Respiratory Medicine|August 2, 2025
Maximising opportunity for therapeutic success: sequential participation in cystic fibrosis nucleic acid-based therapy trialsNicole Mayer-Hamblett, Natanya R Kerper, John P Clancy, et al.
Pageof 38